Pediatric drugs
Discover the landscape of Pediatric drugs in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and intelligence on Pediatric drugs, helping you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.
InnoCare Doses First Patient in Registrational Phase III Head‑to‑Head Trial of Mesutoclax Versus Venetoclax – Challenging the Standard of Care in Treatment‑Naïve AML
InnoCare Pharma (HKG: 9969; SHA: 688428) announced today that the first patient has been dosed in the registrational Phase III head‑to‑head clinical trial of the Company's novel BCL2 inhibitor mesutoclax…
Empowering Chinese Pharma’s Global Expansion
Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
